Clinical Trial Update: PREVENTKD (Prevent Risks by Early interVEntion at Nighttime in Type 1 Diabetes for Kidney Disease) [Phase 3]

View source ↗

Summary

The PREVENTKD Phase 3 trial in type 1 diabetes mellitus was terminated and results were posted in January 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Type 1 Diabetes Mellitus

Snippet

Sponsor: Northwestern University | Conditions: Type 1 Diabetes | Phase 3 | Status: TERMINATED | Results posted: 2015-01-09